SCOR IN CORONARY AND VASCULAR DISEASES
SCOR IN CORONARY AND VASCULAR DISEASES
批准号:
3106493
负责人:
JOSEPH SAMBROOK
金额:
$142.48万
依托单位国家:
美国
项目类别:
财政年份:
1985
资助国家:
美国
项目状态:
已结题
起止时间:
1985-01-01 至 1994-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The Ischemic Heart SCOR at The University of Texas Southwestern Medical
Center at Dallas will continue research directed at elucidating
pathophysiological mechanisms operative during myocardial ischemia and
evolving myocardial infarction. Research work in this SCOR is built upon
the principle that from the elucidation of fundamental mechanisms
responsible for myocardial ischemia and its consequences will come improved
patient care and rehabilitation, and the ability to prevent myocardial
infarction in some individuals at risk. The experimental studies that we
have proposed represent continuations of productive research efforts that
have been ongoing within this Program during the previous 14-1/2 years.
However, 4 new research sections have been added to the Clinical Section
(Project 2) of our Ischemic SCOR Program, including new studies that will
elucidate mechanisms responsible for fish oil diets reducing the risk of
restenosis after coronary angioplasty; studies that will demonstrate
whether serotonin and thromboxane accumulation at sites of coronary artery
injury and stenosis are important physiologically in altering coronary
vascular resistance and flow; and studies that will help develop nuclear
magnetic resonance (NMR) imaging and spectroscopy for the noninvasive
detection of myocardial ischemia and to estimate perfusion, evaluate
segmental and global ventricular function, and detect atherosclerotic
plaques. In addition, new research studies have been added that will
utilize molecular biology methods to: (a) evaluate gap junction proteins
and their role in the regulation of cell-to-cell communication and calcium
binding and determine how their function is altered with ischemic cell
injury (Project 8) and (b) study the interaction between tissue plasminogen
activator and its endogenous inhibitor and develop mutant tissue
plasminogen activators that may be evaluated in relevant animal models (and
later patients) for their thrombolytic potential (Project 9). A new
research section that will evaluate basic mechanisms contributing to the
development of congestive heart failure has also been added (Project 10).
We have also added new research studies to evaluate the role of proteases
in myocyte and vascular injury (Project 7) and study the effects of
myocardial ischemia on the cardiac microcirculation (Project 4). Coronary
heart disease remains a major health hazard in contemporary western
society. This Ischemic SCOR Program has been productive and made important
contributions toward: (a) the elucidation of basic pathophysiologic
mechanisms involved in the evolution of cellular and vascular damage during
myocardial ischemia and infarction; (b) the development of sensitive
methods for the identification of acute myocardial ischemia and infarction
and estimating their extent; and (c) providing improved prognostic insight
so that selected patients at risk for future ischemic heart disease
complications may be identified prior to their development.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SCOR IN CORONARY AND VASCULAR DISEASES
-
批准号:3106495
-
项目类别:
-
资助金额:$165.9万
-
财政年份:1985
-
负责人:JOSEPH SAMBROOK
-
依托单位:
SCOR IN CORONARY AND VASCULAR DISEASES
-
批准号:3106494
-
项目类别:
-
资助金额:$165.39万
-
财政年份:1985
-
负责人:JOSEPH SAMBROOK
-
依托单位:
SCOR IN CORONARY AND VASCULAR DISEASES
-
批准号:2215047
-
项目类别:
-
资助金额:$186.67万
-
财政年份:1985
-
负责人:JOSEPH SAMBROOK
-
依托单位: